DE3775850D1 - Pharmazeutische zubereitung mit verzoegerter freigabe. - Google Patents

Pharmazeutische zubereitung mit verzoegerter freigabe.

Info

Publication number
DE3775850D1
DE3775850D1 DE8787110297T DE3775850T DE3775850D1 DE 3775850 D1 DE3775850 D1 DE 3775850D1 DE 8787110297 T DE8787110297 T DE 8787110297T DE 3775850 T DE3775850 T DE 3775850T DE 3775850 D1 DE3775850 D1 DE 3775850D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparation
delayed release
sustained
drug
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787110297T
Other languages
English (en)
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3775850D1 publication Critical patent/DE3775850D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8787110297T 1986-07-18 1987-07-16 Pharmazeutische zubereitung mit verzoegerter freigabe. Expired - Lifetime DE3775850D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61167865A JPH0816066B2 (ja) 1986-07-18 1986-07-18 持続性薬効製剤

Publications (1)

Publication Number Publication Date
DE3775850D1 true DE3775850D1 (de) 1992-02-20

Family

ID=15857516

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787110297T Expired - Lifetime DE3775850D1 (de) 1986-07-18 1987-07-16 Pharmazeutische zubereitung mit verzoegerter freigabe.

Country Status (13)

Country Link
US (1) US5030455A (de)
EP (1) EP0254978B1 (de)
JP (1) JPH0816066B2 (de)
KR (1) KR960004857B1 (de)
AT (1) ATE71291T1 (de)
CA (1) CA1309656C (de)
DE (1) DE3775850D1 (de)
DK (1) DK174931B1 (de)
ES (1) ES2040228T3 (de)
FI (1) FI96095C (de)
GR (1) GR3003536T3 (de)
NO (1) NO179163C (de)
PH (1) PH25286A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US4975312A (en) * 1988-06-20 1990-12-04 Foster-Miller, Inc. Multiaxially oriented thermotropic polymer substrate for printed wire board
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
GB2263910A (en) * 1992-02-05 1993-08-11 Co Ordinated Drug Dev Direct compression tablet excipient
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
WO1995016434A1 (en) * 1993-12-13 1995-06-22 Lidak Pharmaceuticals Sucrose ester c-20 to c-28 alcohol formulations
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
DE69636706T2 (de) * 1995-09-25 2007-10-11 Ashmont Holdings Ltd., Takapuna Makrocyclische lacton anthelmintika
AU2284697A (en) * 1996-04-11 1997-10-29 University Of British Columbia, The Fusogenic liposomes
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법
IL161857A0 (en) * 2001-11-30 2005-11-20 Pfizer Prod Inc Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
KR101532920B1 (ko) * 2010-12-08 2015-07-01 아이다 엔지니어링, 엘티디. 고강도 소결성형체의 제조방법 및 그 제조장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US4020159A (en) * 1974-10-08 1977-04-26 Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden Methods of and medications for treating cardiac disorders by using strophanthin
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
DE3569080D1 (en) * 1984-08-30 1989-05-03 Rodisma Pharma Prod Gmbh Process for sustaining the release of vitamins c and e

Also Published As

Publication number Publication date
DK373187A (da) 1988-01-19
ATE71291T1 (de) 1992-01-15
PH25286A (en) 1991-04-30
FI873106A (fi) 1988-01-19
EP0254978B1 (de) 1992-01-08
US5030455A (en) 1991-07-09
JPS6327439A (ja) 1988-02-05
NO872991D0 (no) 1987-07-17
ES2040228T3 (es) 1993-10-16
FI96095C (fi) 1996-05-10
EP0254978A1 (de) 1988-02-03
GR3003536T3 (de) 1993-03-16
FI96095B (fi) 1996-01-31
DK174931B1 (da) 2004-03-01
NO179163C (no) 1996-08-21
KR960004857B1 (ko) 1996-04-16
JPH0816066B2 (ja) 1996-02-21
NO179163B (no) 1996-05-13
KR880001301A (ko) 1988-04-22
DK373187D0 (da) 1987-07-17
NO872991L (no) 1988-01-19
CA1309656C (en) 1992-11-03
FI873106A0 (fi) 1987-07-14

Similar Documents

Publication Publication Date Title
DE3775850D1 (de) Pharmazeutische zubereitung mit verzoegerter freigabe.
DE68901140D1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
SE8803486L (sv) Dosform foer behandling av kardiovaskulaera sjukdomar
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
NO875299L (no) Insulinpreparat for ikke-paranteral administrasjon.
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DK148092D0 (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til selektiv nedsaettelse af lipidniveauet i blodet
BG49827A3 (en) Method for preparing a clean byologic active recombinative human colonium stimulating factor
DE68918847D1 (de) Stabile pharmazeutische zusammensetzung.
KR900700492A (ko) N-헤테로사이클릭 프로필리덴-1,1-비스포스폰산, 이의 제조방법 및 약제학적 조성물
ATE97572T1 (de) Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe.
DE68905613D1 (de) Pharmazeutische zubereitung.
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
DE3877365D1 (de) Arzneimittel mit methylcellulose.
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
DE3888800D1 (de) Transdermales Arzneimittelpräparat.
ATE77820T1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
ATA264387A (de) Pharmazeutische verwendung von phenoxypentyloxy-3,4-dihydro-2h-1-benzopyranderivaten
DE3676806D1 (de) Pharmazeutische zusammensetzung und behandlung.
ES1008953Y (es) Un dispositivo para la reconstitucion y administracion de sustancias terapeuticas a pacientes mediante infusion.
ATE105494T1 (de) Verschlusskoerpr zur verabreichung einer physiologisch aktiven substanz.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EISAI R&D MANAGEMENT CO., LTD., TOKYO, JP